Multifunctional γδ t cells and their receptors for targeted anticancer immunotherapy

OncoImmunology

Volumn 2, Issue 5, 2013, Pages

  Scheper, Wouter ^a   Gründer, Cordula ^a   Kuball, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

T cells; Adoptive immunotherapy; Allogeneic stem cell transplantation; Cytomegalovirus; Leukemia; T cell receptor

Indexed keywords

ANTIVIRUS AGENT; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADOPTIVE TRANSFER; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CYTOMEGALOVIRUS INFECTION; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOSURVEILLANCE; LEUKEMIA RELAPSE; MINIMAL RESIDUAL DISEASE; NATURAL KILLER CELL; VIRUS IMMUNITY; VIRUS REACTIVATION;

EID: 84886943710     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23974     Document Type: Article

References (10)

1. Elmaagacli AH, Steckel NK, KoldehoffM, Hegerfeldt Y, Trenschel R, Ditschkowski M, et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011; 118:1402-12; PMID:21540462; http://dx.doi.org/10.1182/blood- 2010-08-304121
2. Scheper W, van Dorp S, Kersting S, Pietersma F, Lindemans C, Hol S, et al. γδ cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 2013; In press; PMID:23277330; http://dx.doi.org/10.1038/leu.2012.374
3. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10:467-78; PMID:20539306; http://dx.doi. org/10.1038/nri2781
4. Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, Merville P, et al. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J Exp Med 2005; 201:1567-78; PMID:15897274; http://dx.doi. org/10.1084/jem.20041851
5. Willcox CR, Pitard V, Netzer S, Couzi L, Salim M, Silberzahn T, et al. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor. Nat Immunol 2012; 13:872-9; PMID:22885985; http://dx.doi.org/10.1038/ni.2394
6. Oevermann L, Lang P, Feuchtinger T, Schumm M, Teltschik HM, Schlegel P, et al. Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation. Ann N Y Acad Sci 2012; 1266:161-70; PMID:22901267; http://dx.doi.org/10.1111/j.1749-6632.2012.06606.x
7. Vantourout P, Hayday A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol 2013; 13:88-100; PMID:23348415; http://dx.doi.org/10.1038/nri3384
8. Marcu-Malina V, van Dorp S, Kuball J. Re-targeting T-cells against cancer by gene-transfer of tumorreactive receptors. Expert Opin Biol Ther 2009; 9:579-91; PMID:19368527; http://dx.doi. org/10.1517/14712590902887018
9. Marcu-Malina V, Heijhuurs S, van Buuren M, Hartkamp L, Strand S, Sebestyen Z, et al. Redirecting aβ T cells against cancer cells by transfer of a broadly tumor-reactive ?dT-cell receptor. Blood 2011; 118:50-9; PMID:21566093; http://dx.doi.org/10.1182/blood- 2010-12-325993
10. Gründer C, van Dorp S, Hol S, Drent E, Straetemans T, Heijhuurs S, et al. γ9 and d2CDR3 domains regulate functional avidity of T cells harboring ?9d2TCRs. Blood 2012; 120:5153-62; PMID:23018643; http://dx.doi.org/10.1182/blood-2012-05-432427